Testing two iron doses in pregnant women with different body fat
Compares 25 mg and 50 mg daily iron in pregnant women with varying body fat.
Key facts
- Who runs it
- University of Ulster
- Where
- Coleraine, United KingdomSee the 2 sites
- Trial code
- Registry title
- Adiposity and Iron Requirements in Pregnancy
- Status
- Recruiting
- People taking part
- 312 people, planned
- Started
- 20 May 2024
- Expected to end
- 19 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Adiposity and Iron Requirements in Pregnancy (ADIPREG)
- Record updated
- 1 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women aged 18 or older, at least 12 weeks pregnant, with one baby and no pregnancy complications. They take 25 or 50 mg of iron daily until delivery.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Pregnant for at least 12 weeks, with one baby confirmed by the first ultrasound scan, and no current pregnancy complications such as severe bleeding, diabetes, hyperemesis gravidarum, or ectopic and molar pregnancies.
- Earlier treatment
- People taking multivitamins can join but are asked to stop any current supplements. People taking steroids, anti-inflammatory treatments or drugs that affect gut absorption (proton-pump inhibitors) cannot join.
- Biomarker or test result
- BMI of 18.5 kg/m2 or more. Haemoglobin (Hb) must not be below 110 g/L. Ferritin (SF) must not be below 30 μg/L.
Main reasons for not taking part
- Multiple pregnancy
- High risk of iron overload (Hb >150 g/L, transferrin saturation >45% or SF >150 μg/L)
- History of blood, kidney, liver or autoimmune disorders, or malabsorptive syndromes
- History of bariatric surgery
- Planned home birth, another research study at the same time, or not speaking English
This trial only enrols pregnant participants. The registry sentence this rests on: Inclusion Criteria:- Pregnant women
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age ≥ 18 years
- BMI ≥18.5 kg/m2
- Without current pregnancy complications (for example, severe bleeding, Diabetes Mellitus, hyperemesis gravidarum, ectopic and molar pregnancies)
- At least 12 Gestational Week
- Singleton pregnancy confirmed with the first ultrasound scan
- Participants who are currently taking multivitamins will be included. They will be asked to discontinue any current supplementation
Who cannot take part
- Participants who take steroids or anti-inflammatory treatments or drugs that affect gut absorption (proton-pump inhibitors)
- Participants with history of haematological, renal, liver, autoimmune disorders, malabsorptive syndromes
- Participants with history of bariatric surgery
- Hb <110 g/L
- SF <30 μg/L
- High risk of iron overload (Hb >150 g/L, transferrin saturation >45% or SF> 150 μg/L)
- Planned home births
- Participants currently involved in another research study
- Multiple pregnancy
- Participants who do not speak English
Where in United Kingdom
- Causeway HospitalColeraine, United KingdomContact: Karen Rodgers, Senior MidwifeTaking people
- Ulster University, Human Intervention Studies UnitColeraine, United KingdomContact: Ruth Price, PhDTaking people
About the trial
What the trial wants to find out
This study aims to explore how body fat influences the response to either 25 or 50 mg of daily iron supplements during pregnancy. We will conduct a double-blind randomized controlled intervention study involving 312 pregnant women recruited from antenatal clinics in the Northern Trust Area. Participants will be randomly assigned to receive either 25 or 50 mg of iron per day from 12 weeks of pregnancy until delivery, using the Active Iron supplement brand. Blood samples will be collected at 12, 28 and 36 weeks gestation and umbilical cord blood will be collected at delivery. Anthropometric measurements will be taken at each visit, and participants will complete questionnaires on various aspects of health and lifestyle, mental health, gastrointestinal symptoms, and compliance.
The 2 groups in the trial
- Iron 25Existing treatment, for comparison
Iron 25 (total 25 mg/d of iron): 2 supplements of 12.5 mg of elemental iron + 1 multivitamin supplement;
Treatment: Adiposity and Iron Requirements in Pregnancy (ADIPREG)
- IRON 50Existing treatment, for comparison
Iron 50 (total 50 mg/d of iron): 2 supplements of 25 mg of elemental iron + 1 multivitamin supplement).
Treatment: Adiposity and Iron Requirements in Pregnancy (ADIPREG)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Maternal Adiposity on Maternal Iron Status and Requirements: a Randomised Intervention Study
- Plain-language title
- Testing two iron doses in pregnant women with different body fatGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 1 July 2026